4//SEC Filing
McKee Kelly T. Jr. 4
Accession 0001437749-23-023737
CIK 0000832489other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:50 PM ET
Size
5.7 KB
Accession
0001437749-23-023737
Insider Transaction Report
Form 4
McKee Kelly T. Jr.
Chief Medical Officer
Transactions
- Award
Stock Option
2023-08-01+15,000→ 15,000 totalExercise: $0.76Exp: 2033-12-07→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance.
- [F2]Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant.
Documents
Issuer
GeoVax Labs, Inc.
CIK 0000832489
Entity typeother
Related Parties
1- filerCIK 0001903889
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:50 PM ET
- Size
- 5.7 KB